Relander, T, Pedersen, M B, Ellin, F, Lauritzsen, G F, Jantunen, E, Hagberg, H, Holte, H, Österborg, A, Nully Brown, P D, Kuittinen, O, Erlanson, M, Østenstad, B, Fagerli, U-M, Delabie, J, Sundström, C, Sander, B, Hamilton-Dutoit, S J, Ehinger, M, Liestøl, K, Toldbod, H E, Feldman, A L & d'Amore, F A 2022, ' Long-Term Follow-up of Clinical Outcome Determinants and Correlative Biological Features from the Nordic NLG-T-01 Trial ', Blood, vol. 140, no. Supplement 1, pp. 1479–1480 . https://doi.org/10.1182
Leukemia Leukemia, London : Springer Nature, 2021, vol. 35, iss. 7, p. 1894-1906 Modvig, S, Hallböök, H, Madsen, H O, Siitonen, S, Rosthøj, S, Tierens, A, Juvonen, V, Osnes, L T N, Vålerhaugen, H, Hultdin, M, Matuzeviciene, R, Stoskus, M, Marincevic, M, Lilleorg, A, Ehinger, M, Norén-Nystrøm, U, Toft, N, Taskinen, M, Jónsson, O G, Pruunsild, K, Vaitkeviciene, G, Vettenranta, K, Lund, B, Abrahamsson, J, Porwit, A, Schmiegelow, K & Marquart, H V 2021, ' Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting ', Leukemia, vol. 35, pp. 1894–1906 . https://doi.org/10.1038/s41375-020-01100-5